Normal-sized ovary carcinoma syndrome

Area of Science:

• Gynecologic Oncology
• Pathology
• Medical Oncology

Background:

• Diffuse peritoneal metastasis with normal-sized ovaries is a rare clinical presentation.
• This phenomenon, termed "normal-sized ovary carcinoma syndrome," poses diagnostic and therapeutic challenges.

Purpose of the Study:

• To investigate the clinical and pathological characteristics of the normal-sized ovary carcinoma syndrome.
• To identify distinct diagnostic groups and evaluate survival outcomes and treatment strategies.

Main Methods:

• Retrospective review of clinical records and pathology slides for 11 cases identified between 1976 and 1987.
• Classification of cases into four diagnostic groups: mesothelioma, extragonadal müllerian tumors, metastatic tumors of unknown origin, and ovarian carcinoma.

Main Results:

• Four diagnostic groups were identified: mesothelioma (4 patients), extragonadal müllerian tumors (2 patients), metastatic tumors of unknown origin (4 patients), and ovarian carcinoma (1 patient).
• Survival was generally less than 1 year for mesothelioma, extragonadal müllerian tumors, and metastatic tumors of unknown origin.
• Mesothelioma survival may improve with combined radiotherapy, adriamycin-based chemotherapy, and debulking surgery.

Conclusions:

• Accurate diagnosis is crucial for appropriate management of the normal-sized ovary carcinoma syndrome.
• Treatment strategies vary significantly by diagnosis, with specific recommendations for mesothelioma and metastatic tumors of unknown origin.
• Perioperative radiologic assessment, surgical exploration, and interdisciplinary communication are essential for discerning tumor origin.